Dalemo Sofia, Eggertsen Robert, Hjerpe Per, Almqvist Erik G, Boström Kristina Bengtsson
a Institute of Medicine/Dept. of Public Health and Community/Primary Health Care , Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
b Närhälsan R&D Centre , Skaraborg Primary Care , Skövde , Sweden.
Scand J Prim Health Care. 2018 Jun;36(2):198-206. doi: 10.1080/02813432.2018.1459430. Epub 2018 Apr 6.
Elevated calcium concentration is a commonly used measure in screening analyses for primary hyperparathyroidism (pHPT) and cancer. Low bone mineral density (BMD) and osteoporosis are common features of pHPT and strengthen the indication for parathyroidectomy. It is not known whether an elevated calcium concentration could be a marker of low BMD in suspected pHPT patients with a normal parathyroid hormone concentration.
To study if low BMD and osteoporosis are more common after ten years in patients with elevated compared with normal calcium concentrations at baseline.
Prospective case control study.
Primary care, southern Sweden.
One hundred twenty-seven patients (28 men) with baseline elevated, and 254 patients (56 men) with baseline normal calcium concentrations, mean age 61 years, were recruited. After ten years, 77% of those still alive (74 with elevated and 154 with normal calcium concentrations at baseline) participated in a dual energy x-ray absorptiometry measurement for BMD assessment and analysis of calcium and parathyroid hormone concentrations.
Association between elevated and normal calcium concentration at base-line and BMD at follow-up. Correlation between calcium and parathyroid hormone concentrations and BMD at follow-up.
A larger proportion of the patients with elevated baseline calcium concentrations who participated in the follow-up had osteoporosis (p value = 0.036), compared with the patients with normal concentrations. In contrast, no correlation was found between calcium or parathyroid hormone concentrations and BMD at follow-up.
In this study, patients with elevated calcium concentrations at baseline had osteoporosis ten years later more often than controls (45% vs. 29%), which highlights the importance of examining these patients further using absorptiometry, even when their parathyroid hormone level is normal. Key Points Osteoporosis is common, difficult to detect and usually untreated. It is not known whether elevated calcium concentrations, irrespective of the PTH level, could be a marker of low bone mineral density. No correlation was found between calcium or parathyroid hormone concentrations and bone mineral density at follow-up. In this study, patients with elevated calcium concentrations at baseline had osteoporosis ten years later more often than controls (45% vs. 29%).
血钙浓度升高是原发性甲状旁腺功能亢进症(pHPT)和癌症筛查分析中常用的指标。低骨密度(BMD)和骨质疏松是pHPT的常见特征,也是甲状旁腺切除术指征的强化因素。在甲状旁腺激素浓度正常的疑似pHPT患者中,血钙浓度升高是否可能是低BMD的一个标志物尚不清楚。
研究与基线血钙浓度正常的患者相比,基线血钙浓度升高的患者在十年后发生低BMD和骨质疏松的情况是否更常见。
前瞻性病例对照研究。
瑞典南部的初级保健机构。
招募了127例(28例男性)基线血钙浓度升高的患者和254例(56例男性)基线血钙浓度正常的患者,平均年龄61岁。十年后,仍存活的患者中有77%(基线血钙浓度升高的74例和正常的154例)参与了双能X线吸收测定以评估BMD,并分析血钙和甲状旁腺激素浓度。
基线时血钙浓度升高与正常和随访时BMD之间的关联。随访时血钙和甲状旁腺激素浓度与BMD之间的相关性。
参与随访的基线血钙浓度升高的患者中,骨质疏松的比例高于血钙浓度正常的患者(p值 = 0.036)。相比之下,随访时血钙或甲状旁腺激素浓度与BMD之间未发现相关性。
在本研究中,基线血钙浓度升高的患者在十年后发生骨质疏松的情况比对照组更常见(45% 对 29%),这突出了即使这些患者的甲状旁腺激素水平正常,也需进一步使用吸收测定法对其进行检查的重要性。要点 骨质疏松很常见,难以检测且通常未得到治疗。无论PTH水平如何,血钙浓度升高是否可能是低骨密度的一个标志物尚不清楚。随访时血钙或甲状旁腺激素浓度与骨密度之间未发现相关性。在本研究中,基线血钙浓度升高的患者在十年后发生骨质疏松的情况比对照组更常见(45% 对 29%)。